Reagents

Aptiva®

Aptiva’s particle-based multi-analyte technology (PMAT) simultaneously detects multiple autoantibodies, increasing clinical confidence and diagnostic precision. Realize the full potential of multi-analyte testing with clinically significant biomarkers that demonstrate excellent clinical performance.

Increase diagnostic power with antibody profiling.

Aptiva delivers a more complete diagnostic profile to support clinical decision-making. Robust antibody profiles have higher diagnostic confidence than individual antibodies, and the probability of disease increases with multiple positive antibodies.

 

 

Bizzaro N, et al. Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases. Arthritis Res & Ther. 2022;24:278

Reagents

View systems
Contact Us

Contact us directly using the below, or by filling out the form.

Tel: 01925 810 141 - Option 6

 

Tel: 0800 102 6342

 

Tel: 01925 810 141 - Option 1

DATA PROCESSING NOTICE:

Werfen Ltd will process your personal data to respond to your requests for information or support, or to understand your needs and provide you with a better service relying on our legitimate interest to do so. You can find more information about our data privacy practices and how to exercise your rights in our Privacy Policy. You can also contact us at DPO-uk@werfen.com.